Compare BKR & AFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKR | AFL |
|---|---|---|
| Founded | 2016 | 1955 |
| Country | United States | United States |
| Employees | 64000 | N/A |
| Industry | Metal Fabrications | Accident &Health Insurance |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5B | 56.8B |
| IPO Year | 2017 | 1994 |
| Metric | BKR | AFL |
|---|---|---|
| Price | $63.28 | $112.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 11 |
| Target Price | $58.50 | ★ $110.36 |
| AVG Volume (30 Days) | ★ 9.1M | 2.1M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | 1.45% | ★ 2.17% |
| EPS Growth | ★ 56.02 | 23.78 |
| EPS | 2.98 | ★ 4.21 |
| Revenue | ★ $27,733,000,000.00 | $18,927,000,000.00 |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $6.10 | $1.58 |
| P/E Ratio | ★ $21.39 | $26.69 |
| Revenue Growth | N/A | ★ 1.21 |
| 52 Week Low | $33.62 | $96.95 |
| 52 Week High | $64.26 | $119.32 |
| Indicator | BKR | AFL |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 48.61 |
| Support Level | $44.09 | $106.74 |
| Resistance Level | N/A | $115.84 |
| Average True Range (ATR) | 1.54 | 2.96 |
| MACD | 0.07 | -0.37 |
| Stochastic Oscillator | 85.63 | 12.20 |
Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.